Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Oblimersen |
Trade Name | |
Synonyms | Genasense|augmerosen|G3139 |
Drug Descriptions |
Genasense (oblimersen) is an antisense oligonucleotide that targets BCL-2, resulting in decreased protein expression, which potentially leads to increased tumor cell apoptosis (PMID: 24667300). |
DrugClasses | BCL2 inhibitor 27 |
CAS Registry Number | 190977-41-4 |
NCIT ID | C66722 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Nab-paclitaxel + Oblimersen + Temozolomide | Nab-paclitaxel Oblimersen Temozolomide | 0 | 0 |
Oblimersen | Oblimersen | 0 | 0 |